|
G1 |
G2 |
G3 |
G4 |
Glucose mg/dL |
110.93±21.58a |
110.69±9.8a |
309.2±56.26c |
164.79±44.16b |
Maternal weight gain (g) |
127.11±12.82c |
137.57±15.77c |
63.84±27.07a |
88.83±13.46b |
Number of corpora lutea |
11.63±2.33a |
12.13±1.95a |
9.88±0.83a |
10.63±1.92a |
Number of implantation sites |
11.25±2.31a |
11.75±2.18a |
9.43±1.51a |
10.25±1.90a |
Number of live foetuses |
11.13±2.64a |
11.63±1.76a |
8.88±1.25a |
9.88±2.29a |
Pre-implantation loss (%) |
3.24a |
3.39a |
4.17a |
3.43a |
Post-implantation loss (%) |
1.64a |
0.41a |
4.97b |
4.34b |
Mean ± SD. All data were statistically analysed using analysis of variance (ANOVA) followed by the Tukey test. Means followed by different letters indicate significant
differences between the groups (p<0.05). G1= non-diabetic, G2= non-diabetic treated with quercetin, G3= diabetic and G4= diabetic treated with quercetin. |